miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 18, Issue 18, Pages 1671-1682
Publisher
Future Medicine Ltd
Online
2017-11-27
DOI
10.2217/pgs-2017-0115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-509-3p Inhibits Cancer Cell Proliferation and Migration via Upregulation of XIAP in Gastric Cancer Cells
- (2017) Jihong Sun et al. ONCOLOGY RESEARCH
- Improving microRNA target prediction with gene expression profiles
- (2016) Cesaré Ovando-Vázquez et al. BMC GENOMICS
- MicroRNA-509–3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis
- (2016) Wei Chen et al. PHARMACOGENOMICS
- miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
- (2016) Yinghong Pan et al. Oncotarget
- Small molecule compounds targeting miRNAs for cancer therapy
- (2015) Paloma del C. Monroig et al. ADVANCED DRUG DELIVERY REVIEWS
- Plant miRNAs: biogenesis, organization and origins
- (2015) Hikmet Budak et al. FUNCTIONAL & INTEGRATIVE GENOMICS
- Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer
- (2015) WAN-SIK LEE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Small molecule Mcl-1 inhibitors for the treatment of cancer
- (2015) Johannes Belmar et al. PHARMACOLOGY & THERAPEUTICS
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells
- (2014) Yue Wang et al. CANCER LETTERS
- Targeting miRNAs for Pancreatic Cancer Therapy
- (2014) Min Shi et al. CURRENT PHARMACEUTICAL DESIGN
- Inhibition of Cell Proliferation and Migration by miR-509-3p That Targets CDK2, Rac1, and PIK3C2A
- (2014) Sena Yoon et al. MOLECULES AND CELLS
- Targeting BCL2 for the Treatment of Lymphoid Malignancies
- (2014) Mary Ann Anderson et al. SEMINARS IN HEMATOLOGY
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells
- (2013) Fang Wang et al. FEBS LETTERS
- MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells
- (2013) Yu-mei Rao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Large-Scale Screens of miRNA-mRNA Interactions Unveiled That the 3′UTR of a Gene Is Targeted by Multiple miRNAs
- (2013) Peng Zhou et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer
- (2009) Melissa Crawford et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now